Titan Medical Past Earnings Performance

Past criteria checks 3/6

Titan Medical has been growing earnings at an average annual rate of 21.7%, while the Medical Equipment industry saw earnings growing at 13.4% annually. Revenues have been growing at an average rate of 28% per year. Titan Medical's return on equity is 145.3%, and it has net margins of 39.4%.

Key information

21.7%

Earnings growth rate

60.8%

EPS growth rate

Medical Equipment Industry Growth8.9%
Revenue growth rate28.0%
Return on equity145.3%
Net Margin39.4%
Last Earnings Update31 Dec 2023

Recent past performance updates

Recent updates

Titan Medical reports Q2 results

Aug 11

Titan Medical granted 180-day extension to regain compliance with Nasdaq's minimum bid price rule

Jun 29

Titan Medical: Developing Single-Access Robotic Assisted Surgical Technologies

Dec 05

Titan Medical earns milestone payment of $10M under licensing deal with Medtronic; shares rise 10%

May 28

Titan Medical announces $15M bought deal offering

Feb 02

Titan Medical announces $10M bought deal offering

Jan 05

Titan medical provides regulatory update on its Enos Robotic Single Access System

Dec 30

Titan Medical in full compliance with Nasdaq listing criteria

Dec 24

Revenue & Expenses Breakdown
Beta

How Titan Medical makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

OTCPK:TMDI.F Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 2318770
30 Sep 2317-2117
30 Jun 2317-121115
31 Mar 230-361124
31 Dec 220-431133
30 Sep 2210-211137
30 Jun 2210-191240
31 Mar 2220-91140
31 Dec 2120-151238
30 Sep 2120-451134
30 Jun 2120-381025
31 Mar 2120-381016
31 Dec 2020-2488
30 Sep 2010-185
30 Jun 2010-1819
31 Mar 200-14837
31 Dec 190-42851
30 Sep 190-53864
30 Jun 190-59856
31 Mar 190-50744
31 Dec 180-23733
30 Sep 180-27722
30 Jun 180-33617
31 Mar 180-29613
31 Dec 170-34613
30 Sep 170-23611
30 Jun 170-11610
31 Mar 170-17515
31 Dec 160-23523
30 Sep 160-34435
30 Jun 160-44442
31 Mar 160-44443
31 Dec 150-41438
30 Sep 150-28429
30 Jun 150-20421
31 Mar 150-19415
31 Dec 140-13311
30 Sep 140-1648
30 Jun 140-1536
31 Mar 140-1035
31 Dec 130-935
30 Sep 130-835

Quality Earnings: TMDI.F has a large one-off loss of $4.0M impacting its last 12 months of financial results to 31st December, 2023.

Growing Profit Margin: TMDI.F became profitable in the past.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: TMDI.F has become profitable over the past 5 years, growing earnings by 21.7% per year.

Accelerating Growth: TMDI.F has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: TMDI.F has become profitable in the last year, making it difficult to compare its past year earnings growth to the Medical Equipment industry (6.3%).


Return on Equity

High ROE: TMDI.F's Return on Equity (145.3%) is considered outstanding.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.